Keyphrases
4sU-seq
20%
Adverse Metabolic Effects
20%
Anti-inflammatory Drugs
20%
Bromodomain-containing Protein 4 (BRD4)
40%
Common Mechanisms
20%
Control Genes
20%
Enhancer RNA (eRNA)
100%
Gene Expression
20%
Glucocorticoid Receptor
60%
Glucocorticoid Response
40%
Glucocorticoid Signaling
20%
Glucocorticoid Therapy
100%
H3K27 Acetylation
20%
Hepatocytes
20%
Histone Acetylation
20%
Immune Cells
20%
Inflammatory Macrophages
20%
Intergenic
20%
Molecular Mechanism
20%
Murine Liver
20%
Murine Macrophages
100%
Nascent Transcription
20%
Non-coding RNA (ncRNA)
20%
Nuclear Receptor
20%
Primary murine Macrophages
20%
Publicly Available
20%
Putative Drug Targets
20%
Receptor-binding Domain
20%
RNA Expression
100%
Target Gene Expression
40%
Tissue-specific Enhancers
20%
Transcriptional Targets
20%
Transcriptomic Data
20%
Type-specific
60%
Biochemistry, Genetics and Molecular Biology
Acetylation
16%
Binding Site
16%
BRD4
33%
Enhancer Region
16%
Enhancer RNAs
100%
Gene Expression
33%
Gene Expression Control
16%
Glucocorticoid
100%
Glucocorticoid Receptor
66%
Hepatocyte
16%
Histone Acetylation
16%
Immunocompetent Cell
16%
Macrophage
100%
Non-Coding RNA
16%
Nuclear Receptor
16%
Receptor Binding
16%
Transcription
16%
Transcriptomics
16%
Immunology and Microbiology
Acetylation
10%
Binding Site
10%
Enhancer Region
100%
Gene Expression
30%
Glucocorticoid
100%
Histone Acetylation
10%
Immunocompetent Cell
10%
Macrophage
100%
Receptor Binding
10%
Transcriptomics
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinflammatory Agent
16%
Binding Site
16%
Cell Nucleus Receptor
16%
Glucocorticoid
100%
Glucocorticoid Receptor
66%
Histone
16%
Untranslated RNA
16%